Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2723

TR 365 Mouse Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                    PENTAERYTHRITOL TETRANITRATE


NTP Experiment-Test: 05023-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/04/94
Route: DOSED FEED                                                                                                 Time: 02:05:42




       Facility:  TSI Mason Research

       Chemical CAS #:  78-11-5

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                               7           12            7                                                  
    Moribund                                           5            8            5                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                38           30           38                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (46)         (41)         (43)                                                
      Inflammation, Acute                                           1 (2%)                                                          
   Intestine Large, Colon                             (49)         (11)         (49)                                                
      Parasite                                                                   1 (2%)                                             
   Intestine Small, Duodenum                          (46)         (11)         (43)                                                
      Epithelium, Hyperplasia                          1 (2%)                    1 (2%)                                             
      Lymphoid Nodule, Hyperplasia                                  1 (9%)                                                          
   Intestine Small, Ileum                             (47)         (11)         (46)                                                
      Lymphoid Nodule, Mineralization                  1 (2%)                                                                       
   Intestine Small, Jejunum                           (46)         (11)         (44)                                                
      Hyperplasia                                                   1 (9%)                                                          
   Liver                                              (49)         (50)         (49)                                                
      Basophilic Focus                                 1 (2%)       1 (2%)       2 (4%)                                             
      Clear Cell Focus                                 1 (2%)       3 (6%)       1 (2%)                                             
      Eosinophilic Focus                                                         3 (6%)                                             
      Fatty Change, Diffuse                            2 (4%)       1 (2%)                                                          
      Fatty Change, Focal                              1 (2%)       5 (10%)      2 (4%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                              6 (12%)                                                         
      Hemorrhage                                                    1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                         6 (12%)      3 (6%)       2 (4%)                                             
      Pigmentation                                     1 (2%)                    1 (2%)                                             
      Thrombosis                                                                 1 (2%)                                             
   Mesentery                                                       (6)          (1)                                                 
      Inflammation, Acute                                           3 (50%)                                                         
      Fat, Necrosis                                                 3 (50%)                                                         
   Pancreas                                           (49)         (13)         (49)                                                
      Cyst                                                          1 (8%)                                                          
      Fibrosis                                                                   1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)                    2 (4%)                                             
      Necrosis                                                                   2 (4%)                                             
      Acinus, Atrophy                                  2 (4%)       3 (23%)      3 (6%)                                             
      Acinus, Hypertrophy                              1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Duct, Dilatation                                              1 (8%)                                                          
   Stomach, Forestomach                               (49)         (50)         (49)                                                
      Acanthosis                                       2 (4%)       5 (10%)      4 (8%)                                             
      Edema                                                                      1 (2%)                                             
      Hyperkeratosis                                  11 (22%)     10 (20%)     13 (27%)                                            
      Inflammation, Chronic Active                     2 (4%)                    1 (2%)                                             
      Necrosis                                                      2 (4%)                                                          
   Stomach, Glandular                                 (47)         (49)         (48)                                                
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Chronic Active                     3 (6%)       4 (8%)      10 (21%)                                            
      Mineralization                                   2 (4%)       1 (2%)       1 (2%)                                             
   Tooth                                                                        (1)                                                 
      Incisor, Developmental Malformation                                        1 (100%)                                           
      Incisor, Inflammation, Acute                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (12)         (49)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mineralization                                   1 (2%)                                                                       
      Thrombosis                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (49)         (12)         (49)                                                
      Capsule, Hyperplasia                            40 (82%)      7 (58%)     43 (88%)                                            
   Adrenal Gland, Cortex                              (48)         (12)         (49)                                                
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hyperplasia                                     36 (75%)      7 (58%)     38 (78%)                                            
      Hypertrophy                                      3 (6%)                    2 (4%)                                             
   Adrenal Gland, Medulla                             (47)         (11)         (47)                                                
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
   Islets, Pancreatic                                 (49)         (12)         (48)                                                
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (45)         (15)         (42)                                                
      Pars Distalis, Angiectasis                       4 (9%)       2 (13%)      1 (2%)                                             
      Pars Distalis, Hyperplasia                       8 (18%)      2 (13%)     10 (24%)                                            
   Thyroid Gland                                      (47)         (12)         (47)                                                
      Follicular Cell, Hyperplasia                     1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (50)         (19)         (48)                                                
      Abscess                                                       2 (11%)                                                         
      Angiectasis                                                                3 (6%)                                             
      Cyst                                             9 (18%)      2 (11%)      9 (19%)                                            
      Degeneration, Cystic                             1 (2%)       6 (32%)      2 (4%)                                             
      Hemorrhage                                       1 (2%)       1 (5%)       2 (4%)                                             
      Hyperplasia, Papillary                           1 (2%)                                                                       
      Mineralization                                                             2 (4%)                                             
      Necrosis                                                                   1 (2%)                                             
      Pigmentation                                                               2 (4%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Bilateral, Abscess                                            2 (11%)      1 (2%)                                             
   Uterus                                             (49)         (37)         (49)                                                
      Abscess                                                       1 (3%)                                                          
      Angiectasis                                      2 (4%)       1 (3%)                                                          
      Hemorrhage                                                    1 (3%)                                                          
      Inflammation, Chronic Active                     3 (6%)       3 (8%)       2 (4%)                                             
      Necrosis                                                                   1 (2%)                                             
      Pigmentation                                                  1 (3%)                                                          
      Endometrium, Hyperplasia                        36 (73%)     19 (51%)     38 (78%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (12)         (49)                                                
      Myelofibrosis                                    5 (10%)                   4 (8%)                                             
   Lymph Node                                         (50)         (17)         (48)                                                
      Axillary, Hematopoietic Cell Proliferation                    1 (6%)                                                          
      Axillary, Infiltration Cellular, Plasma Cell                  1 (6%)                                                          
      Lumbar, Angiectasis                              1 (2%)                                                                       
      Lumbar, Hematopoietic Cell Proliferation                      1 (6%)                                                          
      Lumbar, Infiltration Cellular, Plasma Cell                    1 (6%)       1 (2%)                                             
      Mediastinal, Angiectasis                         1 (2%)                                                                       
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
          Cell                                                      2 (12%)                                                         
      Pancreatic, Hematopoietic Cell Proliferation                               1 (2%)                                             
      Renal, Hematopoietic Cell Proliferation                       1 (6%)                                                          
      Renal, Infiltration Cellular, Plasma Cell                     1 (6%)       1 (2%)                                             
   Lymph Node, Mandibular                             (40)         (8)          (42)                                                
      Hematopoietic Cell Proliferation                 2 (5%)       2 (25%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hyperplasia, Lymphoid                            1 (3%)                                                                       
   Lymph Node, Mesenteric                             (48)         (12)         (46)                                                
      Angiectasis                                      3 (6%)       1 (8%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)       3 (25%)      3 (7%)                                             
   Spleen                                             (50)         (50)         (50)                                                
      Angiectasis                                      1 (2%)                                                                       
      Hematopoietic Cell Proliferation                35 (70%)     20 (40%)     34 (68%)                                            
      Hemorrhage                                                                 1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
      Lymphoid Follicle, Hyperplasia                   4 (8%)       5 (10%)      2 (4%)                                             
   Thymus                                             (42)         (10)         (40)                                                
      Hyperplasia, Lymphoid                                         1 (10%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (39)         (5)          (34)                                                
      Necrosis                                                      1 (20%)                                                         
      Acinus, Hyperplasia                              1 (3%)                                                                       
   Skin                                               (49)         (13)         (46)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Necrosis                                                      1 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (12)         (49)                                                
      Mineralization                                   5 (10%)                   2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (16)         (49)                                                
      Congestion                                       1 (2%)                                                                       
      Edema                                            2 (4%)                    1 (2%)                                             
      Hemorrhage                                       6 (12%)      1 (6%)       3 (6%)                                             
      Infiltration Cellular, Histiocyte                3 (6%)       1 (6%)                                                          
      Inflammation, Acute                                           1 (6%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    1 (2%)                                             
      Pleura, Inflammation, Acute                                                1 (2%)                                             
   Nose                                               (43)         (9)          (48)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Nasolacrimal Duct, Inflammation, Acute                        1 (11%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (14)         (49)                                                
      Casts                                                                      1 (2%)                                             
      Cyst                                                                       2 (4%)                                             
      Glomerulosclerosis                                                         1 (2%)                                             
      Inflammation, Acute                                           1 (7%)                                                          
      Inflammation, Chronic Active                                               1 (2%)                                             
      Papilla, Mineralization                                       2 (14%)      1 (2%)                                             
      Renal Tubule, Pigmentation                                                 1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          15            6            9                                                  
    Dead                                               8            6            3                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                26           38           38                                                  
  Wrong Sex                                            1                                                                            
  Animals Examined Microscopically                    49           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large                                    (47)         (8)          (47)                                                
      Anus, Necrosis                                                             1 (2%)                                             
   Intestine Small, Ileum                             (44)         (6)          (47)                                                
      Lymphoid Nodule, Hyperplasia                     1 (2%)       1 (17%)      3 (6%)                                             
   Intestine Small, Jejunum                           (44)         (7)          (47)                                                
      Lymphoid Nodule, Hyperplasia                                  2 (29%)      2 (4%)                                             
   Liver                                              (48)         (24)         (49)                                                
      Angiectasis                                                   2 (8%)                                                          
      Clear Cell Focus                                                           1 (2%)                                             
      Cyst                                             1 (2%)       1 (4%)       2 (4%)                                             
      Eosinophilic Focus                               1 (2%)                                                                       
      Fatty Change, Diffuse                            1 (2%)                                                                       
      Fatty Change, Focal                              6 (13%)                                                                      
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hemorrhage                                                    1 (4%)                                                          
      Infarct                                          1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
      Mixed Cell Focus                                 1 (2%)                    2 (4%)                                             
      Necrosis                                         2 (4%)       3 (13%)      2 (4%)                                             
      Pigmentation                                     1 (2%)                                                                       
      Bile Duct, Hyperplasia                           1 (2%)                                                                       
   Mesentery                                          (4)          (4)          (2)                                                 
      Inflammation, Acute                              1 (25%)                                                                      
      Fat, Mineralization                              1 (25%)      1 (25%)      1 (50%)                                            
      Fat, Necrosis                                    3 (75%)      4 (100%)     2 (100%)                                           
   Pancreas                                           (47)         (13)         (47)                                                
      Acinus, Atrophy                                                            1 (2%)                                             
      Acinus, Necrosis                                 1 (2%)                                                                       
      Artery, Necrosis, Fibrinoid                      1 (2%)                                                                       
   Stomach, Forestomach                               (47)         (49)         (46)                                                
      Acanthosis                                       3 (6%)       1 (2%)                                                          
      Hyperkeratosis                                   3 (6%)       4 (8%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
   Stomach, Glandular                                 (47)         (47)         (47)                                                
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)       6 (13%)      6 (13%)                                            
      Mineralization                                   1 (2%)                                                                       
   Tooth                                              (1)                                                                           
      Incisor, Developmental Malformation              1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (46)         (13)         (48)                                                
      Capsule, Hyperplasia                            37 (80%)     13 (100%)    45 (94%)                                            
   Adrenal Gland, Cortex                              (46)         (13)         (48)                                                
      Accessory Adrenal Cortical Nodule                1 (2%)                    1 (2%)                                             
      Hyperplasia                                      3 (7%)       1 (8%)       6 (13%)                                            
      Hypertrophy                                      7 (15%)      2 (15%)     13 (27%)                                            
   Adrenal Gland, Medulla                             (45)         (13)         (47)                                                
      Hyperplasia                                      4 (9%)       1 (8%)       8 (17%)                                            
   Islets, Pancreatic                                 (47)         (13)         (46)                                                
      Hyperplasia                                      3 (6%)                                                                       
   Pituitary Gland                                    (45)         (8)          (48)                                                
      Pars Distalis, Cyst                                                        5 (10%)                                            
      Pars Intermedia, Hyperplasia                     1 (2%)                    1 (2%)                                             
   Thyroid Gland                                      (46)         (8)          (46)                                                
      Follicle, Cyst                                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (19)         (19)         (18)                                                
      Atrophy                                                                    1 (6%)                                             
      Dilatation                                       8 (42%)      5 (26%)      9 (50%)                                            
      Inflammation, Acute                                                        1 (6%)                                             
      Inflammation, Chronic Active                     7 (37%)      6 (32%)      3 (17%)                                            
      Mineralization                                   1 (5%)       1 (5%)                                                          
      Necrosis                                         5 (26%)      6 (32%)      5 (28%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Prostate                                           (43)         (8)          (48)                                                
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
   Seminal Vesicle                                    (47)         (11)         (48)                                                
      Bacterium                                        1 (2%)                                                                       
      Concretion                                       1 (2%)                                                                       
      Fibrosis                                         1 (2%)                                                                       
   Testes                                             (48)         (9)          (49)                                                
      Artery, Necrosis, Fibrinoid                      1 (2%)                                                                       
      Seminiferous Tubule, Atrophy                     2 (4%)                    1 (2%)                                             
      Seminiferous Tubule, Mineralization              1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (46)         (23)         (47)                                                
      Axillary, Angiectasis                            1 (2%)                                                                       
      Axillary, Infiltration Cellular, Lymphocyte      1 (2%)                                                                       
      Iliac, Cyst                                                   1 (4%)                                                          
      Lumbar, Hematopoietic Cell Proliferation         1 (2%)                                                                       
      Mediastinal, Hematopoietic Cell Proliferation                 1 (4%)                                                          
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
          Cell                                                      1 (4%)                                                          
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                1 (4%)                                                          
      Pancreatic, Angiectasis                                       1 (4%)                                                          
      Renal, Hematopoietic Cell Proliferation          1 (2%)                                                                       
   Lymph Node, Mandibular                             (25)         (3)          (28)                                                
      Hematopoietic Cell Proliferation                                           1 (4%)                                             
   Lymph Node, Mesenteric                             (44)         (22)         (45)                                                
      Angiectasis                                     22 (50%)     18 (82%)     24 (53%)                                            
      Hematopoietic Cell Proliferation                15 (34%)     10 (45%)     20 (44%)                                            
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                                         1 (5%)                                                          
   Spleen                                             (47)         (26)         (47)                                                
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Atrophy                                                       1 (4%)                                                          
      Depletion Lymphoid                                                         1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                38 (81%)     12 (46%)     36 (77%)                                            
      Hemorrhage                                                    2 (8%)                                                          
   Thymus                                             (36)         (7)          (42)                                                
      Atrophy                                          3 (8%)                                                                       
      Depletion Lymphoid                                                         1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (48)         (22)         (47)                                                
      Acanthosis                                       2 (4%)                    1 (2%)                                             
      Hemorrhage                                       2 (4%)                                                                       
      Hyperkeratosis                                                             1 (2%)                                             
      Inflammation, Acute                                           1 (5%)       1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Necrosis                                         6 (13%)      3 (14%)      4 (9%)                                             
      Prepuce, Fibrosis                                                          1 (2%)                                             
      Prepuce, Hemorrhage                              1 (2%)       1 (5%)                                                          
      Prepuce, Inflammation, Acute                     2 (4%)       2 (9%)                                                          
      Prepuce, Inflammation, Chronic Active                         1 (5%)                                                          
      Prepuce, Necrosis                                2 (4%)       2 (9%)       1 (2%)                                             
      Scrotal, Epithelium, Hyperplasia, Basal Cell     1 (2%)                                                                       
      Subcutaneous Tissue, Mineralization              1 (2%)                                                                       
      Subcutaneous Tissue, Necrosis                                 1 (5%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (48)         (31)         (50)                                                
      Joint, Hyperostosis                                           2 (6%)                                                          
      Tarsal, Hyperostosis                            23 (48%)     21 (68%)     25 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (48)         (9)          (50)                                                
      Mineralization                                   4 (8%)                    4 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (47)         (17)         (50)                                                
      Atelectasis                                      1 (2%)                                                                       
      Congestion                                       2 (4%)       1 (6%)       4 (8%)                                             
      Edema                                            1 (2%)                                                                       
      Hemorrhage                                       6 (13%)      1 (6%)       4 (8%)                                             
      Infiltration Cellular, Histiocyte                3 (6%)       3 (18%)      3 (6%)                                             
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (4%)       1 (6%)       3 (6%)                                             
   Nose                                               (40)         (7)          (48)                                                
      Inflammation, Acute                              1 (3%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05023-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 02:05:42  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Harderian Gland                                    (1)          (3)          (5)                                                 
      Hyperplasia                                                                1 (20%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (47)         (13)         (49)                                                
      Casts Protein                                                 1 (8%)       1 (2%)                                             
      Congestion                                       1 (2%)                    2 (4%)                                             
      Cyst                                             1 (2%)                                                                       
      Fibrosis                                         1 (2%)                                                                       
      Inflammation, Acute                              1 (2%)                    1 (2%)                                             
      Cortex, Mineralization                          12 (26%)      3 (23%)      8 (16%)                                            
      Papilla, Mineralization                          1 (2%)       1 (8%)       1 (2%)                                             
      Papilla, Necrosis                                                          1 (2%)                                             
      Renal Tubule, Regeneration                                    1 (8%)                                                          
   Urinary Bladder                                    (45)         (15)         (47)                                                
      Angiectasis                                                                1 (2%)                                             
      Calculus Gross Observation                                    4 (27%)      2 (4%)                                             
      Calculus Micro Observation Only                  2 (4%)       5 (33%)      8 (17%)                                            
      Inflammation, Chronic Active                     2 (4%)                    1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Transitional Epithelium, Hyperplasia             1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 70035-70035/70035


--multipart-boundary--